Streamlining and Non-Compliant Intact Mass Analysis of Biotherapeutic mAbs with the Biopharmaceutical Platform Solution
22 May 2013The Biopharmaceutical Platform Solution with UNIFI® enables a fully integrated workflow for intact mass analysis, including acquisition, processing, and reporting, for organizations in early development and those operating under regulatory compliant environments. The ability to automate and standardize intact mass analysis enables laboratories to deploy their scientific resources with greater efficiency and effect.
Related Products
Request Quote for All Products
ACQUITY UPLC H-Class PLUS Bio System
WatersThe ACQUITY UPLC H-Class PLUS Bio System delivers the benefits of UPLC's resolution, sensitivity, and throughput in a system purpose-built for the analysis of proteins, peptides, nucleic acids, and glycans.
Biopharmaceutical Platform Solution with UNIFI
WatersThe Waters Biopharmaceutical Platform Solution with UNIFI® integrates robust UPLC®/MS characterization technology with the UNIFI Scientific Information System for applications in bioseparations, intact protein mass analysis, peptide mapping and released glycan analysis.This platform unites all aspects of biotherapeutic analyses and workflows, enabling organizations to apply high resolution analytics across the development process continuum. The platform captures complex mass spectrometry and chromatography data, and enables laboratories to comprehensively and routinely acquire, process, and share LC and MS characterization information throughout a biotherapeutic’s lifecycle. Results can be shared from discovery to development to GxP quality control.